Trials / Completed
CompletedNCT06224790
Perfenidone in Type 2 Diabetic Patients With Diabetic Neuropathy
Effectiveness & Safety of Perfenidone in Type 2 Diabetic Patients With Diabetic Neuropathy: A Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Sidrah Lodhi · Academic / Other
- Sex
- All
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the effectiveness \& safety of pirfenidone in type 2 diabetic patients with diabetic nephropathy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pirfenidone | Capsule Pirfenidone 1200mg/ day in divided doses for 3 months |
| OTHER | Placebo | 2 Capsules 3 times a day for 3 months |
Timeline
- Start date
- 2024-03-10
- Primary completion
- 2025-03-07
- Completion
- 2025-03-07
- First posted
- 2024-01-25
- Last updated
- 2025-03-11
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT06224790. Inclusion in this directory is not an endorsement.